Authorised AIF ICAV
Name:
OrbiMed Royalty ICAV
Reference No:
C549796
Date of Authorisation
22 Apr 2025
Status:
ICAV
Notes:
- This fund may be marketed to Qualifying Investors only in accordance with the Central Bank of Ireland’s AIF Rulebook/NU Notices and therefore a minimum subscription of Euro 100,000 is required.
- This fund was authorised by the Central Bank of Ireland as an umbrella investment fund which may comprise open-ended and/or closed-ended and/or open-ended with limited liability sub-funds.
AIFM:
Reference Number
Name
C551809
OrbiMed Advisors LLC
Management Company:
Reference Number
Name
Depositary:
Reference Number
Name
C438084
CSC Depositary Services (Ireland) Limited
Sub-Funds:
Reference No:
Name
Date of Approval
C559331
OrbiMed Royalty Investments IV
22 Apr 2025
C559332
OrbiMed Royalty Investments V
22 Apr 2025
Page last updated on:
13 Oct 2025